Acorda Therapeutics, Inc.
ACORDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001008848
Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Acorda Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Acorda Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Panem Sandra PhD | Director | – | Jun 23, 2023 | 0 |
| Kelley John P | Director | – | Jun 23, 2023 | 0 |
| Varian John | Director | – | Jun 23, 2023 | 0 |
| Jensen Peder | Director | – | Jun 23, 2023 | 0 |
| Burns Thomas M. | Director | – | Jun 23, 2023 | 0 |
| Cohen Ron | President and CEO | 149,757 | Apr 4, 2023 | 0 |
| Belloff Neil S. | General Counsel and Corp Secy | – | Apr 4, 2023 | 0 |
| Clem Kerry M | Chief Commercial Officer | 10,083 | Apr 4, 2023 | 0 |
| Sabella Lauren M | Chief Operating Officer | 10,710 | Sep 7, 2022 | 0 |
| Randall Lorin | Director | – | Jun 14, 2022 | 0 |
| Gesser Michael A | Chief Financial Officer | – | Nov 9, 2021 | 0 |
| Morales Robert | Interim PAO & PFO | 4,423 | Sep 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 (view filing) | Mar 16-17 | 4 days | Cohen RonPresident and CEO | PPurchase | +20.2K | $0.6248 | +$12.6K | +15.6%149.8K after | 2 lots |
| Mar 21, 2022 (view filing) | Mar 17 | 4 days | Cohen RonPresident and CEO | SSale | −2.29K | $1.70 | −$3.89K | −1.7%129.6K after |